Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis2018-01-17T17:05:43-05:00
Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-up Study Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-up Study2018-01-17T17:05:43-05:00
Growth factor treatment of demyelinating disease: at last, a leap into the light Growth factor treatment of demyelinating disease: at last, a leap into the light2018-01-17T17:05:11-05:00
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange2018-01-17T17:03:58-05:00
Heterogeneity of Multiple Sclerosis Lesions: Implications for the Pathogenesis of Demyelination Heterogeneity of Multiple Sclerosis Lesions: Implications for the Pathogenesis of Demyelination2018-01-17T17:00:56-05:00